News Focus
News Focus
Post# of 257269
Next 10
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 217991

Thursday, 09/20/2018 11:41:07 AM

Thursday, September 20, 2018 11:41:07 AM

Post# of 257269
OMED -13% on CELG’s declining option to license Navicixizumab:

https://finance.yahoo.com/news/oncomed-provides-navicixizumab-partnership-120000730.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today